Please assess the completion status of the following clinical trial:

Trial Title: Metformin in Assisted Reproduction-MET-AR-study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Fulfilling Rotterdam criteria for PCOS~* Infertility more than 1 year~* First or second cycle of IVF/ICSI treatment~* Age below 38 years at inclusion~* BMI below 28 kg/m3 at inclusion~* Willing to be randomised to 4 months metformin or placebo~* Signed written informed consent~Exclusion Criteria:~* Not suitable for starting dose 112.5 IE~* Basal FSH above 10 IU/L~* Known renal disease or s-creatinine above 110 umol/L~* Known liver disease or s-ALAT above 80 IU/L~* Known alcoholism or drug abuse~* Known diabetes mellitus or fasting plasma glucose above 7 mmol/L~* Corticosteroid treatment (oral)~* Treatment with cimetidine, anticoagulants, erythromycin or other macrolides~* Hyperprolactinemia (PRL above 700 mIU/L)~* Abnormal thyroid function tests~* Known congenital adrenal hyperplasia~* Androgen secreting tumours~* Cushing syndrome~* Metformin treatment within the last one month prior to screening~* Unfit to participate for any other reason

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 38 Years
- Healthy Volunteers: t

Study Arms:
- M: Metformin P: Placebo (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).